Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation (ADORE-GAINS)

University of Kansas

Status: Active, not recruiting

Conditions: Pregnancy; Nutritional Diseases

Treatments: Dietary Supplement: Docosahexaenoic acid

Study type: Observational

Funder types: Other

Identifiers

NCT03310983

STUDY00140895

Details and patient eligibility

About

The purpose of this study is to learn if participants in the ADORE study (NCT02626299), who took a DHA supplement during pregnancy, see favorable body fat in their infants from birth to 24 months, and if excessive or appropriate weight gain during pregnancy impacts this result.

Enrollment: 254 patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Participants for this study are invited from the parent study, ADORE. Eligibility listed reflects criteria for the ADORE study.

Inclusion Criteria:

• Agree to consume study capsules and a typical prenatal supplement of 200 mg DHA
• Available by telephone

Exclusion Criteria:

• Expecting multiple infants
• Gestational age at baseline <12 weeks or >20 weeks
• Unable or unwilling to agree to consume capsules until delivery
• Unwilling to discontinue use of another prenatal supplement with DHA that contains ≥ 200 mg DHA
• Women with allergy to any component of DHA product (including algae), soybean oil or corn oil

Trial design

254 participants in 1 patient group

ADORE Participants

Description:

Participants enrolled in the ADORE study are invited to participate in this study.

Treatment:

Dietary Supplement: Docosahexaenoic acid